APA Alıntı

Ksienski, D., Wai, E. S., Alex, D., Croteau, N. S., Freeman, A. T., Chan, A., . . . Lesperance, M. (2021). Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab. Transl Lung Cancer Res.

Chicago Stili Alıntı

Ksienski, Doran, et al. "Prognostic Significance of the Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio for Advanced Non-small Cell Lung Cancer Patients With High PD-L1 Tumor Expression Receiving Pembrolizumab." Transl Lung Cancer Res 2021.

MLA Alıntı

Ksienski, Doran, et al. "Prognostic Significance of the Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio for Advanced Non-small Cell Lung Cancer Patients With High PD-L1 Tumor Expression Receiving Pembrolizumab." Transl Lung Cancer Res 2021.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..